MPO and amyotrophic lateral sclerosis: This is attributed to the amount of myeloperoxidase (MPO), as substantially more myeloperoxidase-expressing cells were detected in SOD1 (~8-fold) and C9orf72 (~2-fold) ALS patients’ brains compared to controls [56].